• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Mass Tort News

Mass Tort News

News Articles for Mass Tort Attorneys

  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us
  • Sponsorships
Home / Hernia Mesh / Hernia Mesh Plaintiff Receives $4.8 Million in First Bellwether Trial Against CR Bard

Hernia Mesh Plaintiff Receives $4.8 Million in First Bellwether Trial Against CR Bard

Categories: Hernia Mesh August 30, 2022 by Christina Grube Leave a Comment

Providence County Courthouse, Rhode Island

By Christina Grube

(MASS TORT NEWS) The Rhode Island state court hernia mesh bellwether trial versus medical device producer Bard yielded a plaintiff’s victory with the jury awarding $4.8 million to plaintiff Paul Trevino.

The Rhode Island trial began in July with lead plaintiff lawyer Jonathan Rent of Motley Rice LLC alleging that Bard knew the polypropylene resin used in their Ventralex hernia mesh caused damage to the patient’s body tissue, yet continued selling the product. Orent of Motley Rice LLC explained that the Ventralex patch caused his client so much pain that Mr. Trevino underwent a second surgery to have the mesh removed and later received a bowel resection from the damage the resin caused.

“4000 people hurt severely by this device in the last 3 years alone. 25 percent, one in four people that were implanted with this device had another surgery to take it out.” Orent said. “That’s what the evidence in this case is.”

The Bard defense team denied the medical-giant knew their products to be damaging and noted that all surgeons inform patients of the potentially severe side effects and risks that come with hernia mesh surgery.

“It’s still on the market today,” said Defense attorney Jeff Scott of Greenberg Traurig. “It was cleared by the FDA. It’s never been recalled.”
Bard remains involved in multiple MDLs over negligence and faulty product design. The Ohio-based Bard MDL no. 2846 remains the largest active hernia mesh MDL with over 16,000 claims. Bellwether trials began in 2021 with Bard winning the first round. Though the Bard victory surprised many, Ronald V. Miller noted a historic pattern of big pharma winning the first Bellwether trial. However the second Bellwether trial in April 2022 yielded a victory for plaintiffs. The court awarded Mr. Antonio Milanesi and the late Mrs. Milanesi a $255,000 settlement – $250,000 in compensatory damages and $5,000 loss of consortium.

Christina Grube
Share on Facebook Share
Share on TwitterTweet
Share on LinkedIn Share
Send email Mail

Categories: Hernia Mesh

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

Search

Stay updated

Subscribe

Sign up to receive weekly updates on the latest in Mass Tort News.

Footer

Search

Main Navigation

  • Home
  • News
  • LegalCast
  • Live Trials
  • Meet the Team
  • Contact Us
  • Sponsorships

Categories

Events

Trial Lawyers Summit 2022

February 16, 2022 By Mass Tort News

2021 Trial Lawyers Summit Recap

May 11, 2021 By Mark York

2021 TRIAL LAWYERS SUMMIT

May 4, 2021 By Mass Tort News

More Posts from this Category

MASS TORT NEWS

Latest Mass Tort Litigation News

Connect with MTN!

  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube

Copyright © 2023 · Mass Tort News · All Rights Reserved.